TMDX FY 2023 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$242M+158.5% YoY

Gross Profit

$154M63.8% margin

Operating Income

-$29M-11.9% margin

Net Income

-$25M-10.4% margin

EPS (Diluted)

$-0.77

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$192M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$706M

Total Liabilities

$569M

Stockholders' Equity

$137M

Cash & Equivalents

$395M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$242M	$93M	+158.5%
Gross Profit	$154M	$65M	+136.1%
Operating Income	-$29M	-$31M	+8.6%
Net Income	-$25M	-$36M	+30.9%